Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
AGCO
AGCO
$7.1B
| $5.2M | ﹤0.01% |
67,300
+18,000
| +37% | +$1.38M |
|
1827
SPX Corp
SPXC
$10.9B
| $5.2M | ﹤0.01% |
+102,100
| New | +$4.67M |
|
1828
Byline Bancorp
BY
$1.78B
| $5.19M | ﹤0.01% |
265,000
+48,500
| +22% | +$886K |
|
1829
Republic Bancorp
RBCAA
$1.92B
| $5.18M | ﹤0.01% |
110,700
-4,600
| -4% | -$208K |
|
|
EXFO
1830
DELISTED
EXFO INC.
EXFO
| $5.18M | ﹤0.01% |
1,119,578
+7,738
| +0.7% | +$32.5K |
|
1831
CONMED
CNMD
$1.51B
| $5.18M | ﹤0.01% |
+46,281
| New | +$4.93M |
|
1832
Hurco Companies Inc
HURC
$146M
| $5.17M | ﹤0.01% |
134,782
-3,800
| -3% | -$134K |
|
1833
Farmers National Banc Corp
FMNB
$966M
| $5.17M | ﹤0.01% |
316,600
+33,000
| +12% | +$503K |
|
|
RFP
1834
DELISTED
Resolute Forest Products Inc.
RFP
| $5.17M | ﹤0.01% |
1,230,138
+178,538
| +17% | +$741K |
|
|
DERM
1835
DELISTED
Dermira, Inc.
DERM
| $5.17M | ﹤0.01% |
340,849
-484,349
| -59% | -$4.18M |
|
1836
Pixelworks
PXLW
$44.4M
| $5.15M | ﹤0.01% |
109,436
+19,692
| +22% | +$807K |
|
1837
Plains All American Pipeline
PAA
$16.9B
| $5.15M | ﹤0.01% |
279,800
+79,599
| +40% | +$1.46M |
|
|
PDCO
1838
DELISTED
Patterson Companies, Inc.
PDCO
| $5.14M | ﹤0.01% |
250,804
+134,300
| +115% | +$2.54M |
|
1839
Hawaiian Electric Industries
HE
$2.03B
| $5.12M | ﹤0.01% |
109,300
-190,900
| -64% | -$8.55M |
|
1840
Voya Financial
VOYA
$9.2B
| $5.12M | ﹤0.01% |
+83,900
| New | +$4.73M |
|
1841
Cullen/Frost Bankers
CFR
$10.6B
| $5.11M | ﹤0.01% |
52,300
-172,400
| -77% | -$16M |
|
1842
HCI Group
HCI
$2.29B
| $5.11M | ﹤0.01% |
111,919
-6,000
| -5% | -$265K |
|
1843
Q2 Holdings
QTWO
$4.04B
| $5.11M | ﹤0.01% |
63,000
-73,900
| -54% | -$5.68M |
|
1844
Flexsteel Industries
FLXS
$301M
| $5.11M | ﹤0.01% |
256,293
+29,875
| +13% | +$521K |
|
|
AJRD
1845
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $5.11M | ﹤0.01% |
111,800
-532,995
| -83% | -$24.1M |
|
|
ONC
1846
BeOne Medicines Ltd
ONC
$39.3B
| $5.08M | ﹤0.01% |
+30,619
| New | +$5.09M |
|
1847
Metropolitan Bank Holding Corp
MCB
$1.17B
| $5.07M | ﹤0.01% |
105,200
+48,417
| +85% | +$2.14M |
|
1848
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $5.07M | ﹤0.01% |
+55,500
| New | +$5.06M |
|
1849
RPM International
RPM
$14.5B
| $5.07M | ﹤0.01% |
66,000
-143,100
| -68% | -$10.4M |
|
1850
RF Industries
RFIL
$148M
| $5.05M | ﹤0.01% |
746,700
+25,978
| +4% | +$162K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.